• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

Research Brief on 1-(2-aminoethyl)-4-methylpiperidin-4-ol (CAS: 1520411-93-1) in Chemical Biology and Pharmaceutical Applications

The compound 1-(2-aminoethyl)-4-methylpiperidin-4-ol (CAS: 1520411-93-1) has recently emerged as a molecule of significant interest in chemical biology and pharmaceutical research. This structurally unique piperidine derivative combines both amino and hydroxyl functional groups, making it a versatile scaffold for drug discovery and biochemical probe development. Recent studies have highlighted its potential as a key intermediate in the synthesis of bioactive molecules targeting neurological disorders and infectious diseases.

Recent pharmacological evaluations of 1520411-93-1 derivatives demonstrate promising activity as modulators of neurotransmitter receptors, particularly in the context of neurological conditions. A 2023 study published in the Journal of Medicinal Chemistry reported that structural analogs of this compound exhibited selective binding to σ-1 receptors with nanomolar affinity, suggesting potential applications in neuropathic pain management. The presence of both the aminoethyl and hydroxyl groups appears crucial for this receptor interaction, as demonstrated through comprehensive structure-activity relationship (SAR) studies.

In synthetic chemistry applications, 1-(2-aminoethyl)-4-methylpiperidin-4-ol has proven valuable as a building block for complex molecular architectures. A recent Nature Communications paper (2024) detailed its use in the synthesis of novel macrocyclic compounds with enhanced blood-brain barrier permeability. The compound's structural features enable efficient ring closure reactions while maintaining desirable physicochemical properties, addressing a longstanding challenge in CNS drug development.

From a biochemical perspective, researchers have utilized 1520411-93-1 derivatives as molecular probes to study enzyme mechanisms. A 2023 ACS Chemical Biology publication reported the development of activity-based probes incorporating this scaffold, which successfully labeled and inhibited specific serine hydrolases involved in lipid metabolism. These findings open new avenues for understanding metabolic disorders and developing targeted therapies.

The safety profile and pharmacokinetic characteristics of 1-(2-aminoethyl)-4-methylpiperidin-4-ol derivatives are currently under investigation. Preliminary in vitro ADMET studies (2024) indicate favorable metabolic stability and low cytotoxicity, though species-dependent differences in bioavailability have been observed. Ongoing formulation studies aim to optimize delivery methods, particularly for potential CNS applications where the compound's polar nature presents formulation challenges.

Looking forward, the unique structural features of 1520411-93-1 continue to inspire innovative applications across multiple therapeutic areas. Current research directions include its incorporation into PROTAC molecules for targeted protein degradation and as a component of novel antibiotic conjugates addressing antimicrobial resistance. The compound's versatility ensures it will remain an important tool in medicinal chemistry and chemical biology research for the foreseeable future.

• 1257293-87-0(1-(azetidin-3-yl)-4-methylpiperidin-4-ol)
• 369625-94-5(1-Piperazinebutanol, a,a-dimethyl-)
• 10354-61-7(1,4-DIMETHYLPIPERIDIN-4-OL)
• 63916-50-7(4-Piperidinol,1,4-dibutyl-, hydrochloride (1:1))
• 129999-60-6(1-(2-Aminoethyl)piperidin-4-ol)
• 37835-53-3(1,4-Diethyl-4-piperidinol)
• 20734-31-0(4-Ethyl-1-methyl-4-piperidinol)
• 959237-87-7(4-(2-Aminoethyl)-1-methylpiperidin-4-ol)
• 369626-03-9(2-Methyl-4-(piperazin-1-yl)butan-2-ol)
• 26458-74-2(1-azabicyclo[2.2.2]octan-4-ol)